Published • loading... • Updated
Zavation Medical Products Announces First Implantations of Varisync® ALIF NanoPrime™
The Varisync ALIF NanoPrime implant combines PEEK and titanium, improving fusion potential and biomechanical compatibility, with post-op symptom relief reported by the patient.
- On Nov. 15, 2025, Zavation Medical Products, LLC announced the first successful implantations of the Varisync ALIF NanoPrime System, featuring proprietary titanium ion bond technology.
- By combining PEEK and titanium, the system enhances radiographic visualization, biomechanical compatibility, and fusion potential, supported by data from the Department of Biomedical Materials Science, School of Dentistry, University of Mississippi Medical Center.
- Dr. Hanbing Zhou performed a two-level anterior lumbar fusion using the NanoPrime ALIF cage, with the patient reporting symptom improvement post-operatively.
- Zavation says the Varisync ALIF NanoPrime aims to improve surgical outcomes and patient quality of life, while Dr. Zhou highlights its advantages in visualization and biomechanical compatibility for patients receiving ALIF.
- At NASS Booth #1621, Zavation will showcase the Varisync ALIF NanoPrime Interbody System, supported by surface characterization research and internal data from the Department of Biomedical Materials Science, School of Dentistry, University of Mississippi Medical Center.
Insights by Ground AI
35 Articles
35 Articles
+34 Reposted by 34 other sources
Zavation Medical Products Announces First Implantations of Varisync® ALIF NanoPrime™
FLOWOOD, Miss., Nov. 15, 2025 /PRNewswire/ -- Zavation Medical Products, LLC ("Zavation"), a leading innovator in spinal device technology, announces the first successful implantations of the Varisync® ALIF NanoPrime™ System, a next-generation stand-alone ALIF system featuring Zavation's proprietary titanium ion…
Coverage Details
Total News Sources35
Leaning Left4Leaning Right5Center7Last UpdatedBias Distribution44% Center
Bias Distribution
- 44% of the sources are Center
44% Center
L 25%
C 44%
R 31%
Factuality
To view factuality data please Upgrade to Premium
















